by Integumen_1 | Jul 29, 2019 | Cellulac, Investors, Labskin, LabskinTattoo, Updates, Wound pHase
Wound pHase CBD infused chronic wound care & burn products Integumen today announces the expansion of its wound care division, LifeScienceHub Ltd (Wound pHase), as it extends its license technology agreement (RNS 16 July 2018) with Cellulac plc (9.35% owned by...
by Integumen_1 | Jul 16, 2019 | Investors, Labskin, Labskin AI, StoerForMen, Updates
Lab-to-Market time of skincare products, at a fraction of the cost We have entered a new era where an Artificially Intelligent (AI) Laboratory today is becoming more science, than science fiction. There is a paradigm shift going on with the outdated pharmaceutical...
by Integumen_1 | Jul 10, 2019 | Financials, Investors, Labskin, StoerForMen, Updates
Strong H1 2019 Revenue Growth Continues Trading Update The positive results of major restructuring in H2 2018 has delivered accelerated growth in product sales and service contract services across the Group into H1 2019 with a continuation of strong growth expected in...
by Integumen_1 | May 28, 2019 | Labskin, Labskin AI, StoerForMen, Updates
Three new Labskin AI contracts, including CBD infused tampons to relieve period cramp Integumen today announces that Labskin AI, the virtual laboratory platform, has entered into testing agreements with three new clients – a leading chain drug store, a European...
by Integumen_1 | May 21, 2019 | Financials, Investors, Labskin, StoerForMen, Updates
Trading update – board changes Trading Update Integumen announces the resignation of Tony Richardson as Chairman and a director of the Company and Ross Andrews has been appointed as Chairman, with immediate effect. The Company expects to announce an additional...
by Integumen_1 | May 12, 2019 | Labskin, Labskin AI, Updates
Launch of Labskin human skin clone tests for Medical Device and Clinical Research trials Integumen today announces the roll-out of the Labskin human clone skin testing platform into the medical device and clinical research sectors. Combined with human volunteers...
Recent Comments